Showing results (21-30 of 95) with videos related to

Sort By:
Pageof 10
Expert Opinion on Therapeutic Targets|February 25, 2009
Chronic beta-AR activation-induced calpain activation and impaired eNOS-Akt signaling mediates cardiac injury in ovariectomized female ratsMd Shenuarin Bhuiyan, Norifumi Shioda, Kohji Fukunaga
Menopause (New York, N.Y.)|August 17, 2011
Distinct cardioprotective effects of 17β-estradiol and dehydroepiandrosterone on pressure overload-induced hypertrophy in ovariectomized female ratsHideaki Tagashira, Shenuarin Bhuiyan, Norifumi Shioda, et al.
Biochimica Et Biophysica Acta|September 2, 2014
Methyl pyruvate rescues mitochondrial damage caused by SIGMAR1 mutation related to amyotrophic lateral sclerosisHideaki Tagashira, Yasuharu Shinoda, Norifumi Shioda, et al.
Journal of Neurochemistry|June 30, 2006
Generation of constitutively active calcineurin by calpain contributes to delayed neuronal death following mouse brain ischemiaNorifumi Shioda, Shigeki Moriguchi, Yasufumi Shirasaki, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|April 7, 2011
[Regulation of dopaminergic neuronal activity by heart-type fatty acid binding protein in the brain]Yui Yamamoto, Norifumi Shioda, Yuji Owada, et al.
Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology|August 2, 2011
[Dopamine D2 receptor as a novel target molecule for heart-type fatty acid binding protein]Norifumi Shioda, Yui Yamamoto, Yuji Owada, et al.
Expert Opinion on Therapeutic Targets|August 21, 2010
Targeting sigma-1 receptor with fluvoxamine ameliorates pressure-overload-induced hypertrophy and dysfunctionsMd Shenuarin Bhuiyan, Hideaki Tagashira, Norifumi Shioda, et al.
Life Sciences|December 31, 2013
Fluvoxamine rescues mitochondrial Ca2+ transport and ATP production through σ(1)-receptor in hypertrophic cardiomyocytesHideaki Tagashira, Md Shenuarin Bhuiyan, Norifumi Shioda, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|April 7, 2011
[Neurochemical mechanisms of a novel Alzheimer's disease therapeutics on improvement of cognition and depressive behavior]Norifumi Shioda, Yui Yamamoto, Feng Han, et al.
Pageof 10